Cuba teams with China's Lukang to manufacture biotech products; Catalent, BASF take on solubility challenges;

> Cuba's Center for Genetic Engineering and Biotechnology and Lukang Pharmaceutical in China announced plans to cooperatively manufacture and market biotechnology products. Item

> Catalent and BASF will jointly market technology to address drug solubility issues to help companies formulate optimal dose form from development through scale-up and supply. Story

> Nepal's Department of Drug Administration is writing good manufacturing practice (GMP) regulations that will meet World Health Organization (WHO) standards in expectation of raising drug manufacturing standards and making the country's pharmaceuticals more acceptable internationally. Article

> US Pharmacopeia (USP) is investing $1.5 million and looking for donors to set up a facility which will fund itself offering quality control services to pharmaceutical manufacturers in Sub-Saharan Africa. Story

> Omkar Specialty Chemicals in India has acquired LASA Laboratory, which has an API manufacturing facility that makes mostly active ingredients for veterinary pharmaceuticals. More

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.